Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Unity Biotechnology Inc (NQ: UBX )

1.466 +0.036 (+2.52%)
Streaming Delayed Price Updated: 1:25 PM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Unity Biotechnology Inc

< Previous 1 2 3 4 5 Next >
UBX Stock Earnings: Unity Biotechnology Beats EPS for Q1 2024
UBX stock results show that Unity Biotechnology beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
UBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023
UBX stock results show that Unity Biotechnology beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Analyst Ratings for Unity Biotechnology
Via Benzinga
The Latest Analyst Ratings for Unity Biotechnology
Via Benzinga
Where Unity Biotechnology Stands With Analysts
Via Benzinga
Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution
Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ: UBX) from Neutral to Outperform and 
Via Benzinga
Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks
Here are the best longevity stocks to consider. Each stock listed comes with their unique reasons to buy them. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Via Benzinga
Recap: Unity Biotechnology Q1 Earnings
Via Benzinga
Where Unity Biotechnology Stands With Analysts
Via Benzinga
Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 76 companies set new 52-week lows. 
Via Benzinga
Expert Ratings for Unity Biotechnology
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 81 companies hit new 52-week lows. 
Via Benzinga
Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 95 stocks hit new 52-week lows. 
Via Benzinga
Nasdaq Edges Lower; Unity Biotechnology Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to 32,530.40 while the NASDAQ fell 0.09% to 11,813.90. The S&P 500, also... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 89 stocks made new 52-week lows. 
Via Benzinga
Why Is Codiak BioSciences (CDAK) Stock Down 52% Today?
Codiak BioSciences (CDAK) stock is falling hard on Monday after the company announced plans for an asset sale via a Chapter 11 bankruptcy. 
Via InvestorPlace
Gold Drops Over 1%; First Citizens BancShares Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 32,372.55 while the NASDAQ rose 0.01% to 11,825.46. The S&P 500, also... 
Via Benzinga
Why Is Unity Biotechnology (UBX) Stock Down 52% Today?
Unity Biotechnology (UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. 
Via InvestorPlace
UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug
UNITY Biotechnology Inc (NASDAQ: UBX) announced results from Part A of the Phase 2 ENVISION study of UBX1325 in patients with wet age-related macular degeneration (AMD) who were not achieving optimum... 
Via Benzinga
US Stocks Open Higher; Dow Rises 200 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.64% to 32,443.64 while the NASDAQ rose 0.20% to... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.